$XENE CFO Thomas Kelly bought $560K of Xenon Pharmaceuticals stock on the open market.
By Nexqual Desk ·
Tickers: $XENE
$XENE CFO Thomas Kelly bought $560K of Xenon Pharmaceuticals stock on the open market.
15,000 shares at an average $37.32 (Sep 30). It is a new position.
2 different insiders have bought Xenon Pharmaceuticals shares in the last two weeks.
Insiders sell for many reasons. They usually buy for one.
Source: SEC Form 4. Not investment advice.
0 likes
Posted on Nexqual Sonar — the social network for the stock market. Not financial advice.